Achieve Life Sciences, Inc. Payments to Acquire Short-term Investments
Achieve Life Sciences, Inc. (ACHV) reported Payments to Acquire Short-term Investments of $19.45 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2015-03-26
- Achieve Life Sciences, Inc. payments to acquire short-term investments for the quarter ending 2014-12-31 was $14.17M, a 17390.12% increase year-over-year.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for the quarter ending 2014-09-30 was $5.06M, a 226.71% increase year-over-year.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for the quarter ending 2014-06-30 was $164.00K, a 99.13% decline year-over-year.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for the quarter ending 2014-03-31 was $51.00K, a 99.55% decline year-over-year.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for fiscal 2014 was $19.45M, a 38.65% decline from fiscal 2013.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for fiscal 2013 was $31.70M, a 71.30% decline from fiscal 2012.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for fiscal 2012 was $110.44M, a 46.97% increase from fiscal 2011.
- Achieve Life Sciences, Inc. payments to acquire short-term investments for fiscal 2011 was $75.15M, a 19.21% decline from fiscal 2010.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 3 month as first filed | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $19.23M derived: sum of 2 quarters · filed 2015-03-26 | $19.39M derived: sum of 3 quarters · filed 2015-03-26 | $19.45M 10-K · filed 2015-03-26 | |
| 2014-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $5.23M derived: sum of 2 quarters · filed 2014-10-30 | $5.28M 10-Q · filed 2014-10-30 | $5.36M derived: sum of 4 quarters · filed 2015-03-26 | |
| 2014-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $215.00K 10-Q · filed 2014-08-07 | $296.00K derived: sum of 3 quarters · filed 2015-03-26 | $1.85M derived: sum of 4 quarters · filed 2015-03-26 | |
| 2014-03-31 | $51.00K 10-Q · filed 2014-04-30 | $132.00K derived: sum of 2 quarters · filed 2015-03-26 | $1.68M derived: sum of 3 quarters · filed 2015-03-26 | $20.47M derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $1.63M derived: sum of 2 quarters · filed 2015-03-26 | $20.42M derived: sum of 3 quarters · filed 2015-03-26 | $31.70M 10-K · filed 2015-03-26 | |
| 2013-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $20.34M derived: sum of 2 quarters · filed 2014-10-30 | $31.61M 10-Q · filed 2014-10-30 | $57.74M derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-06-30 | $18.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $30.07M 10-Q · filed 2014-08-07 | $56.20M derived: sum of 3 quarters · filed 2015-03-26 | $66.21M derived: sum of 4 quarters · filed 2015-03-26 | |
| 2013-03-31 | $11.28M 10-Q · filed 2014-04-30 | $14.21M 10-Q · filed 2013-05-02 | $37.41M derived: sum of 2 quarters · filed 2015-03-26 | $47.42M derived: sum of 3 quarters · filed 2015-03-26 | $80.01M derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-12-31 | $26.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $36.14M derived: sum of 2 quarters · filed 2015-03-26 | $68.73M derived: sum of 3 quarters · filed 2015-03-26 | $110.44M 10-K · filed 2015-03-26 | |
| 2012-09-30 | $10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $42.60M derived: sum of 2 quarters · filed 2013-11-07 | $84.31M 10-Q · filed 2013-11-07 | $98.87M derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-06-30 | $32.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $74.30M 10-Q · filed 2013-08-08 | $88.86M derived: sum of 3 quarters · filed 2014-03-11 | $105.23M derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-03-31 | $41.71M 10-Q · filed 2013-05-02 | $56.27M derived: sum of 2 quarters · filed 2014-03-11 | $72.64M derived: sum of 3 quarters · filed 2014-03-11 | $88.24M derived: sum of 4 quarters · filed 2014-03-11 | |
| 2011-12-31 | $14.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $30.93M derived: sum of 2 quarters · filed 2014-03-11 | $46.53M derived: sum of 3 quarters · filed 2014-03-11 | $75.15M 10-K · filed 2014-03-11 | |
| 2011-09-30 | $16.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $31.98M derived: sum of 2 quarters · filed 2012-11-08 | $60.59M 10-Q · filed 2012-11-08 | $113.52M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-06-30 | $15.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $44.22M 10-Q · filed 2012-08-02 | $97.15M derived: sum of 3 quarters · filed 2013-03-07 | $124.95M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-03-31 | $28.61M 10-Q · filed 2012-05-03 | $81.55M derived: sum of 2 quarters · filed 2013-03-07 | $109.34M derived: sum of 3 quarters · filed 2013-03-07 | ||
| 2010-12-31 | $52.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $80.73M derived: sum of 2 quarters · filed 2013-03-07 | $93.02M 10-K · filed 2013-03-07 | ||
| 2010-09-30 | $27.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $40.09M 10-Q · filed 2011-11-03 | |||
| 2010-06-30 | $12.29M 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $4.04M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |